Table 2.
Patient, tumor, and procedural characteristics of all minimally invasive pancreatic resections
| Characteristics | Laparoscopic pancreatoduodenectomy N = 52 |
Robotic pancreatoduodenectomy N = 111 |
P | Laparoscopic distal pancreatectomy N = 123 |
|---|---|---|---|---|
| Age, years, median [IQR] | 70 [58–78] | 68 [61–74] | 0.312 | 66 [54–73] |
| Male, n (%) | 24 (46.2) | 67 (60.4) | 0.089 | 59 (48) |
| ASA score | 0.081 | |||
| ASA 1–2. n (%) | 42 (80.8) | 75 (67.6) | 90 (73.2) | |
| ASA 3–4, n (%) | 10 (19.2) | 36 (32.4) | 33 (26.8) | |
| BMI, kg/m2, median [IQR] | 24.2 [21.5–27.9] | 24.9 [22.2–27.1] | 0.481 | 26.3 [22.7–29.3] |
| Neo adjuvant therapy, n (%) | – | 6 (5.4) | 0.057 | 7 (5.7) |
| Size lesion median [IQR] | 18 [15–30] | 23 [17–32] | 0.115 | 30 [21–50] |
| Origin | 0.724 | |||
| Pancreas | 21 (40.4) | 50 (45) | 115 (93.5) | |
| Distal bile duct | 10 (19.2) | 23 (20.7) | 1 (0.8) | |
| Ampullary | 18 (34.6) | 25 (22.5) | – | |
| Duodenum | 2 (3.8) | 10 (9.0) | – | |
| Other | 1 (1.9) | 3 (2.7) | 7 (5.7) | |
| Histological diagnosis | 0.357 | |||
| Adenocarcinoma | 33 (63.5) | 63 (56.8) | 25 (20.3) | |
| Intraductal papillary mucinous neoplasm | 9 (17.3) | 20 (18.0) | 29 (23.6) | |
| Mucinous cystic neoplasm (MCN) | – | 1 (0.9) | 7 (5.7) | |
| Neuroendocrine tumor | 5 (9.6) | 10 (9.0) | 28 (22.8) | |
| Solid-pseudopapillary neoplasm | – | – | 5 (4.1) | |
| Adenoma | 1 (1.9) | 7 (6.3) | – | |
| Pancreatitis | – | 2 (1.8) | 14 (11.4) | |
| Other | 4 (7.7) | 8 (7.2) | 15 (12.2) | |
| Lymph nodes resected in malignant | ||||
| Disease, median [IQR] | 11 [8–15] | 14 [11–17] | 0.016 | 11 [5–16] |
| Involved lymph nodes, median [IQR] | 1 [0–3] | 1 [0–3] | 0.580 | 0 [0–2] |
Values in parentheses are percentages unless mentioned otherwise. Percentages may not add up due to rounding and missing data
IQR interquartile range, BMI body mass index, ASA American Society of Anaesthesiology